溢多利(300381.SZ):世唯科技創始人曾建國完成購買212.15萬股公司股份
格隆匯7月9日丨溢多利(300381.SZ)發佈關於收購長沙世唯科技有限公司少數股權進展暨交易對方完成股票購買的公吿,2021年7月9日,公司接到世唯科技創始人曾建國通知,其已於2021年7月2日至2021年7月8日期間通過二級市場購買溢多利股票212.15萬股,成交均價9.43元/股,累計成交金額2,000.98萬元,已完成協議約定的股票購買承諾,曾建國承諾上述股票將自願鎖定12個月,即自2021年7月8日至2022年7月7日。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.